TRPM2 and non-small cell lung carcinoma: Taking these in vitro and in vivo data together, it is clear that enforced suppression of TRPM2 expression with gene knockdown in osimertinib‐resistant cell lines sensitizes the cells to osimertinib, further suggesting a critical role of TRPM2 modulation in mediating EGFRm NSCLC cell responses to osimertinib.